NCT00132652View on ClinicalTrials.gov

Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B

PHASE3CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Chronic Hepatitis B

Interventions

DRUG

Lamivudine

DRUG

Telbivudine

Trial Locations (14)

Unknown

San Diego

New York

Philadelphia

Westmead

Toronto

Montreal

Beijing

Nice

Tel Aviv

Auckland

Singapore

Tainan City

Chiang Mai

London

Sponsors

Lead Sponsor

Collaborators (1)

Novartis Pharmaceuticals

All Listed Sponsors

collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Novartis

INDUSTRY